Received 17 August 2013
aDepartment of Chemistry and Chemical Technology, Togliatti State University, 14 Belorusskaya St, Togliatti 445667, Russian Federation,bDepartment of Organic, Bioorganic and Medicinal Chemistry, Samara State University, 1 Academician Pavlov St, Samara 443011, Russian Federation, and cX-Ray Structural Centre, A.N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, 28 Vavilov Street, B-334, Moscow 119991, Russian Federation
Correspondence e-mail: email@example.com
The asymmetric unit of the title compound, C20H24N2O2S, contains two independent molecules having very similar geometries. The main N-(6-methoxy-1,3-benzothiazol-2-yl)acetamide moiety adopts an almost planar structure (r.m.s. deviations of 0.091 and 0.051 Å for the two independent molecules). The adamantyl substituent occupies the gauche position relative to the C-N bond of the acetamide moiety [the corresponding N-C-C-C dihedral angles are -100.3 (3) and -96.5 (3)° for the two independent molecules]. In the crystal, the two independent molecules form a dimer via a pair of N-HN hydrogen bonds. The dimers are further linked by C-HO hydrogen bonds and attractive SS [3.622 (2) Å] interactions into ribbons along .
For properties of benzothiazoles as building blocks in organic synthesis, see: Gupta & Rawat (2010); Facchinetti et al. (2012); Sareen et al. (2012); Radatz et al. (2013). For syntheses and properties of 2-substituted benzothiazoles, see: Hussein et al. (2012); Ugale et al. (2012); Yoo et al. (2012); Zhu et al. (2012); Bhardwaj et al. (2013); Patel et al. (2013).
Data collection: APEX2 (Bruker, 2005); cell refinement: SAINT (Bruker, 2001); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: RK2412 ).
The authors are grateful to the Ministry of Education and Science of the Russian Federation (State program No. 3.1168.2011).
Bhardwaj, V. K., Saluja, P., Hundal, G., Hundal, M. S., Singh, N. & Jang, D. O. (2013). Tetrahedron, 69, 1606-1610.
Bruker (2001). SAINT . Bruker AXS Inc., Madison, Wisconsin, USA.
Bruker (2003). SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Bruker (2005). APEX2. Bruker AXS Inc., Madison, Wisconsin, USA.
Facchinetti, V., da Reis, R., Gomes, C. R. B. & Vasconcelos, T. R. A. (2012). Mini-Rev. Org. Chem. 9, 44-53.
Gupta, A. & Rawat, S. (2010). J. Curr. Pharm. Res. 3, 13-23.
Hussein, B. H. M., Azab, H. A., El-Azab, M. F. & El-Falouji, A. I. (2012). Eur. J. Med. Chem. 51, 99-109.
Patel, N. B., Khan, I. H., Pannecouque, C. & De Clercq, E. (2013). Med. Chem. Res. 22, 1320-1329.
Radatz, C. S., Alves, D. & Schneider, P. H. (2013). Tetrahedron, 69, 1316-1321.
Sareen, S., Shinde, D., Khatri, V. & Sareen, V. (2012). Heterocycl. Lett. 2, 361-377.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
Ugale, V. G., Patel, H. M., Wadodkar, S. G., Bari, S. B., Shirkhedkar, A. A. & Surana, S. J. (2012). Eur. J. Med. Chem. 53, 107-113.
Yoo, E., Hayat, F., Rhim, H. & Choo, H. P. (2012). Bioorg. Med. Chem. 20, 2707-2712.
Zhu, X. Y., Etukala, J. R., Eyunni, S. V. K., Setola, V., Roth, B. L. & Ablordeppey, S. Y. (2012). Eur. J. Med. Chem. 53, 124-132.